Targeted Contact Precaution Use to Prevent MRSA Transmission
Targeted Contact Precaution Use to Prevent MRSA Transmission
批准号:
10689825
负责人:
ANTHONY D HARRIS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2025-08-31
关键词:
AddressAdmission activityAntibiotic ResistanceBacteriaBacterial Antibiotic ResistanceCOVID-19 pandemicCaringCessation of lifeClothingCohort StudiesCollaborationsCommunicable DiseasesCountryDataDeimplementationDevelopmentEnrollmentEnsureEpidemiologyFundingGeographyGoalsHIVHandHealth PersonnelHealth ServicesHealthcareHospitalizationHospitalsInfectionInfection ControlInstitutionalizationIntensive Care UnitsInternationalJournalsKnowledgeMedicalMedical centerMethodologyModelingMorbidity - disease rateOutcomePatient CarePatient riskPatientsPeer ReviewPerceptionPoliciesPolicy AnalysisPredispositionPreventionPublic HealthPublishingRecommendationRelaxationResearchResearch PersonnelRiskRisk FactorsScienceSeverity of illnessSiteSocietiesSolidStaphylococcus aureus infectionTimeTranslationsUnited StatesVirus DiseasesWorkacute carecareercomorbiditycomparative cost effectivenesscostcost effectivecost effectivenesscultural healtheffective interventioneffectiveness evaluationevidence basehealth care settingshigh riskinnovationmeetingsmembermethicillin resistant Staphylococcus aureusmortalitymortality riskparticipant enrollmentpathogenpatient populationpersonal protective equipmentpreventproductivity losssymposiumtransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background: There remains tremendous controversy surrounding the pros and cons of contact precautions
for methicillin-resistant Staphylococcus aureus (MRSA). The rationale for this application is that more
knowledge is needed to identify which patients need to be placed on transmission-based contact precautions
(gloves and gowns used by healthcare workers); and when and which patients may not require contact
precautions to prevent the spread of MRSA.
Significance and Impact: Antibiotic resistance is one of the biggest public health challenges of our time. The
application is significant in that it recognizes and addresses the barrier to institutionalizing contact precautions
for all patients with MRSA when busy healthcare personnel (HCP) feel that they may not have time to
continuously don and doff gowns and gloves as they transition from one room to another. If the study results
provide guidance on when contact precautions are most necessary (and when they are not), it may be safe to
recommend reducing the number of times when gowns and gloves are used unnecessarily, while also
providing new evidence on when contact precautions remain essential.
Innovation: The work is innovative in that we are aiming for precision public health to be brought into the field
of antibiotic resistance and all VA medical centers (VAMCs) in the country: the right type of precautions, for
the right type of encounter at the right time.
Specific Aims: Aim 1: Perform a multi-site, geographically diverse cohort study at VA facilities and enroll
patients with MRSA to determine the rate of MRSA transmission to healthcare personnel gloves and gowns in
the ICU and non-ICU setting. Aim 2: Determine which patient risk factors, including comorbid conditions and
severity of illness markers, which patient care interactions and which healthcare personnel types are
associated with greater transmission of MRSA. Aim 3: Develop a dynamic transmission model to compare the
cost-effectiveness of different contact precaution strategies.
Methodology: Across six VAMCs, we will enroll 800 patients who have MRSA in the intensive care unit (ICU)
and non-ICU setting. Research coordinators will randomly observe five healthcare personnel-patient
interactions per patient. Research coordinators will gather data on the patient level factors and on healthcare
personnel patient interaction factors. When the healthcare personnel leave the room, research coordinators
will culture the healthcare personnel's gloves and gown upon room exit. Thus, five healthcare personnel glove
and gown cultures per patient will be obtained, leading to 4,000 glove culture outcomes and 4,000 gown
culture outcomes. The cost-effectiveness aim will use the results from aims 1 and 2 to build a dynamic
transmission model to assess the effectiveness of different contact precaution strategies. For each strategy,
costs will include both direct medical and indirect (i.e., productivity losses) costs.
Implementation/next steps: We will publish our findings in appropriate peer-reviewed scientific journals and
present the results at national scientific forums such as the VA HSR&D Conference, the SHEA Spring Meeting
and IDSA’s IDWeek annual meeting. To ensure successful study implementation and appropriate knowledge
dissemination and translation of findings into policy, we have established an interdisciplinary advisory board
and study site co-investigators with years of expertise in VAMCs. The advisory board members are leaders in
infectious disease in the VHA who have developed and guided the VA MRSA Prevention Initiative over the
years and can implement findings into VA policy. As well, Dr. Harris is a former president of the Society of
Healthcare Epidemiology of America and current member of the CDC HICPAC Advisory group. He will use
these connections to help guide SHEA and CDC policies relative to contact precautions. The VA is an ideal
place to perform this study and have it widely implemented due to its agility in making national policies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted Contact Precaution Use to Prevent MRSA Transmission
-
批准号:10178338
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:ANTHONY D HARRIS
-
依托单位:
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance andOther Adverse Events
-
批准号:10466723
-
项目类别:
-
资助金额:$82.4万
-
财政年份:2021
-
负责人:ANTHONY D HARRIS
-
依托单位:
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance andOther Adverse Events
-
批准号:10403419
-
项目类别:
-
资助金额:$140.68万
-
财政年份:2021
-
负责人:ANTHONY D HARRIS
-
依托单位:
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance andOther Adverse Events
-
批准号:10650204
-
项目类别:
-
资助金额:$142.4万
-
财政年份:2021
-
负责人:ANTHONY D HARRIS
-
依托单位:
Epicenters for the Prevention of Healthcare-Associated Infections (HAIs); Cycle II Multicenter Program Studies
-
批准号:9753064
-
项目类别:
-
资助金额:$71.58万
-
财政年份:2018
-
负责人:ANTHONY D HARRIS
-
依托单位:
Use of electronic data to improve risk adjustment for antibiotic utilization metrics
-
批准号:9981718
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2018
-
负责人:ANTHONY D HARRIS
-
依托单位:
Use of electronic data to improve risk adjustment for antibiotic utilization metrics
-
批准号:9574676
-
项目类别:
-
资助金额:$39.2万
-
财政年份:2018
-
负责人:ANTHONY D HARRIS
-
依托单位:
Epicenters for the Prevention of Healthcare-Associated Infections (HAIs); Cycle II Multicenter Program Studies
-
批准号:10199880
-
项目类别:
-
资助金额:$90.0万
-
财政年份:2018
-
负责人:ANTHONY D HARRIS
-
依托单位:
Epidemiology of CRE and MRSA transmission: patient and organism factors
-
批准号:9986208
-
项目类别:
-
资助金额:$5.3万
-
财政年份:2016
-
负责人:ANTHONY D HARRIS
-
依托单位:
Epidemiology of CRE and MRSA transmission: patient and organism factors
-
批准号:9330060
-
项目类别:
-
资助金额:$58.04万
-
财政年份:2016
-
负责人:ANTHONY D HARRIS
-
依托单位:
Epicenters for the Prevention of Healthcare Associated Infections (HAI) - Cycle II
-
批准号:9076457
-
项目类别:
-
资助金额:$218.11万
-
财政年份:2015
-
负责人:ANTHONY D HARRIS
-
依托单位:
Does Universal Glove and Gown use decrease carbapenem-resistant Gram-negative bacteria
-
批准号:8934663
-
项目类别:
-
资助金额:$48.25万
-
财政年份:2015
-
负责人:ANTHONY D HARRIS
-
依托单位:
Does Universal Glove and Gown use decrease carbapenem-resistant Gram-negative bacteria
-
批准号:9145196
-
项目类别:
-
资助金额:$47.55万
-
财政年份:2015
-
负责人:ANTHONY D HARRIS
-
依托单位:
Does Universal Glove and Gown use decrease carbapenem-resistant Gram-negative bacteria
-
批准号:9348611
-
项目类别:
-
资助金额:$20.85万
-
财政年份:2015
-
负责人:ANTHONY D HARRIS
-
依托单位:
Use of electronic data to improve risk adjustment for hospital infection rates
-
批准号:8560048
-
项目类别:
-
资助金额:$46.76万
-
财政年份:2013
-
负责人:ANTHONY D HARRIS
-
依托单位:
Use of electronic data to improve risk adjustment for hospital infection rates
-
批准号:9052713
-
项目类别:
-
资助金额:$25.44万
-
财政年份:2013
-
负责人:ANTHONY D HARRIS
-
依托单位:
K24 Clinical Research in Antimicrobial Resistance and Hospital Epidemiology
-
批准号:8416369
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2009
-
负责人:ANTHONY D HARRIS
-
依托单位:
K24 Clinical Research in Antimicrobial Resistance and Hospital Epidemiology
-
批准号:7659719
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2009
-
负责人:ANTHONY D HARRIS
-
依托单位:
K24 Clinical research in Antimicrobial Resistance and Hospital Epidemiology
-
批准号:8700018
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2009
-
负责人:ANTHONY D HARRIS
-
依托单位:
K24 Clinical Research in Antimicrobial Resistance and Hospital Epidemiology
-
批准号:8211047
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2009
-
负责人:ANTHONY D HARRIS
-
依托单位: